dexilant– Product Description
Dexilant contains the active ingredient dexlansoprazole. This medication belongs to the proton pump inhibitor (PPI) class. Dexilant reduces stomach acid production and supports treatment for acid-related digestive disorders. Doctors prescribe Dexilant for individuals who experience gastroesophageal reflux disease (GERD) and erosive esophagitis.
The stomach produces acid to assist digestion. Excess acid can irritate the esophagus and cause symptoms such as heartburn, chest discomfort, regurgitation, and throat irritation. Dexilant decreases acid production inside the stomach. Lower acid levels help protect the esophageal lining and support healing of damaged tissue.
Dexlansoprazole blocks proton pumps located in gastric parietal cells. These pumps control acid secretion in the stomach lining. Dexilant interferes with the enzyme system responsible for acid release. Reduced acid production helps relieve persistent reflux symptoms and supports esophageal recovery.
Dexilant capsules contain dual delayed-release technology. The capsule releases dexlansoprazole in two phases. The first release begins shortly after ingestion. The second release occurs later in the digestive tract. This delivery system maintains acid control throughout the day and night.
Doctors recommend Dexilant for patients who struggle with frequent reflux symptoms or damage to the esophageal lining caused by stomach acid exposure. Treatment may relieve burning sensations, swallowing discomfort, and chronic throat irritation. Medical professionals determine dosage based on diagnosis and symptom severity.
dexilant
Patients usually take Dexilant once daily. Capsules can remain intact during swallowing or patients may open the capsule and sprinkle the granules onto soft food if necessary. The granules must remain intact to preserve delayed-release protection.
Medical evaluation remains important before starting treatment. Doctors review digestive symptoms, current medications, and medical history. Long-term acid suppression requires physician monitoring to maintain digestive health and treatment effectiveness.
Dexilant plays an important role in modern acid-reflux management. The medication provides extended acid control and supports healing of the esophagus in individuals who experience chronic reflux conditions.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Dexilant |
| Active Ingredient | Dexlansoprazole |
| Drug Class | Proton Pump Inhibitor (PPI) |
| Dosage Form | Delayed-Release Capsule |
| Available Strengths | 30 mg, 60 mg |
| Administration Route | Oral |
| Indications | GERD, Erosive Esophagitis |
| Mechanism of Action | Inhibits gastric proton pumps to reduce acid production |
| Technology | Dual Delayed-Release Delivery |
| Manufacturer | Takeda Pharmaceuticals |
| Storage | Store at room temperature |
Dexilant provides extended acid control for individuals who struggle with reflux-related digestive conditions. Healthcare professionals rely on this therapy to support esophageal healing and reduce acid-related discomfort.
Reviews
There are no reviews yet.